Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 009 JPY -0.79% Market Closed
Market Cap: 30.8B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daito Pharmaceutical Co Ltd
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Cash Interest Paid
ÂĄ40m
CAGR 3-Years
74%
CAGR 5-Years
14%
CAGR 10-Years
-8%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash Interest Paid
ÂĄ93B
CAGR 3-Years
-6%
CAGR 5-Years
0%
CAGR 10-Years
33%
Daiichi Sankyo Co Ltd
TSE:4568
Cash Interest Paid
ÂĄ1.6B
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
5%
Otsuka Holdings Co Ltd
TSE:4578
Cash Interest Paid
ÂĄ4.1B
CAGR 3-Years
13%
CAGR 5-Years
0%
CAGR 10-Years
10%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash Interest Paid
ÂĄ81m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Daito Pharmaceutical Co Ltd
Glance View

Market Cap
30.7B JPY
Industry
Pharmaceuticals

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Intrinsic Value
2 429.67 JPY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Daito Pharmaceutical Co Ltd's Cash Interest Paid?
Cash Interest Paid
40m JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Cash Interest Paid amounts to 40m JPY.

What is Daito Pharmaceutical Co Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 10Y
-8%

Over the last year, the Cash Interest Paid growth was 208%. The average annual Cash Interest Paid growth rates for Daito Pharmaceutical Co Ltd have been 74% over the past three years , 14% over the past five years , and -8% over the past ten years .

Back to Top